CME Group Berhad Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for CME Group Berhad.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Machinery earnings growth	22.2%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CME Group Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KLSE:CME - Analysts future estimates and past financials data (MYR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	21	-2	N/A	N/A	N/A
3/31/2024	20	-1	N/A	N/A	N/A
12/31/2023	9	-1	N/A	N/A	N/A
9/30/2023	12	-1	-7	-7	N/A
6/30/2023	12	-2	-4	-3	N/A
3/31/2023	13	-4	-5	-5	N/A
12/31/2022	14	-4	-1	0	N/A
9/30/2022	9	-4	-6	-6	N/A
6/30/2022	16	-5	-2	-2	N/A
3/31/2022	11	2	-3	-2	N/A
12/31/2021	11	1	-2	-1	N/A
9/30/2021	10	1	-2	-1	N/A
6/30/2021	4	3	-17	-16	N/A
3/31/2021	6	-3	-17	-17	N/A
12/31/2020	14	-2	-9	-9	N/A
9/30/2020	30	1	-6	-6	N/A
6/30/2020	29	0	4	4	N/A
3/31/2020	52	-17	9	9	N/A
12/31/2019	46	-19	3	3	N/A
9/30/2019	34	-23	7	7	N/A
6/30/2019	38	-24	5	5	N/A
6/30/2018	27	-9	-6	-6	N/A
3/31/2018	42	-4	N/A	-14	N/A
12/31/2017	41	-4	N/A	-11	N/A
9/30/2017	48	-17	N/A	-14	N/A
6/30/2017	39	-16	N/A	-1	N/A
3/31/2017	27	-15	N/A	-1	N/A
12/31/2016	25	-15	N/A	5	N/A
9/30/2016	21	-16	N/A	11	N/A
6/30/2016	24	-15	N/A	6	N/A
3/31/2016	25	-14	N/A	2	N/A
12/31/2015	22	-14	N/A	-12	N/A
9/30/2015	18	3	N/A	-18	N/A
6/30/2015	18	2	N/A	-15	N/A
3/31/2015	19	3	N/A	-11	N/A
12/31/2014	22	3	N/A	3	N/A
9/30/2014	29	0	N/A	2	N/A
6/30/2014	30	0	N/A	1	N/A
3/31/2014	31	0	N/A	1	N/A
12/31/2013	30	1	N/A	0	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if CME's forecast earnings growth is above the savings rate (3.6%).

Earnings vs Market: Insufficient data to determine if CME's earnings are forecast to grow faster than the MY market

High Growth Earnings: Insufficient data to determine if CME's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if CME's revenue is forecast to grow faster than the MY market.

High Growth Revenue: Insufficient data to determine if CME's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CME's Return on Equity is forecast to be high in 3 years time

CME Group Berhad Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Is CME Group Berhad (KLSE:CME) Using Too Much Debt?

Third quarter 2024 earnings released: RM0.001 loss per share (vs RM0 in 3Q 2023)

Is CME Group Berhad (KLSE:CME) Using Debt In A Risky Way?

New major risk - Financial position

Second quarter 2024 earnings released: RM0.001 loss per share (vs RM0.001 loss in 2Q 2023)

First quarter 2024 earnings released: EPS: RM0.001 (vs RM0 in 1Q 2023)

CME Group Berhad, Annual General Meeting, Mar 20, 2024

Full year 2023 earnings released: RM0.001 loss per share (vs RM0.005 loss in FY 2022)

CME Group Berhad Announces Appointment of Ym Tengku Munawirah Putra as Independent Director

CME Group Berhad has filed a Follow-on Equity Offering in the amount of MYR 3.60561 million.

Full year 2023 earnings released: RM0.001 loss per share (vs RM0.005 loss in FY 2022)

CME Group Berhad (KLSE:CME) Has Debt But No Earnings; Should You Worry?

CME Group Berhad Announces Redesignation of Miss Ong Suan Pin from Non Independent and Non Executive Director

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0 in 3Q 2022)

Is CME Group Berhad (KLSE:CME) Using Debt In A Risky Way?

CME Group Berhad Announces the Resignation of Encik Reza Bin Shariffudin as Independent and Non-Executive Chairman of the Nomination Committee

Second quarter 2023 earnings released: EPS: RM0 (vs RM0 in 2Q 2022)

Is CME Group Berhad (KLSE:CME) Using Debt Sensibly?

CME Group Berhad, Annual General Meeting, Dec 15, 2022

First quarter 2023 earnings released: RM0.001 loss per share (vs RM0.001 loss in 1Q 2022)

CME Group Berhad Announces Resignation of Setia Tengku Indera Pahlawan Tengku Putra Alhaj Bin Tengku Azman Shah Alhaj as Independent and Non Executive Chairman of Remuneration Committee

Insufficient new directors

Full year 2022 earnings released: RM0.005 loss per share (vs RM0.003 profit in FY 2021)

Full year 2022 earnings released: RM0.005 loss per share (vs RM0.003 profit in FY 2021)

CME Group Berhad (KLSE:CME) Has Debt But No Earnings; Should You Worry?

Third quarter 2022 earnings released: EPS: RM0 (vs RM0.001 loss in 3Q 2021)

CME Group Berhad (KLSE:CME) Is Carrying A Fair Bit Of Debt

Insufficient new directors

CME Group Berhad Announces Kuala Lumpur High Court Dismisses the Originating Summons for Fortuna Injunction

CME Group Berhad Announces Update on Writ of Summon and Statement of Claim Filed by Bellajade Sdn Bhd

CME Group Berhad Announces Resignation of Gerard Thavanesan A/L Nicholas Paulian as Chief Operating Officer

CME Group Berhad Provides Update on Material Litigation

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Is CME Group Berhad (KLSE:CME) A Risky Investment?

CME Group Berhad Provides Update on Material Litigation

Is CME Group Berhad (KLSE:CME) A Risky Investment?

Would CME Group Berhad (KLSE:CME) Be Better Off With Less Debt?

Third quarter 2021 earnings released: RM0.001 loss per share (vs RM0.001 profit in 3Q 2020)

Here's Why CME Group Berhad (KLSE:CME) Has A Meaningful Debt Burden

CME Group Berhad Provides Update on Litigation

CME Group Berhad Announces Appointment of Yap Wai Yee as Chief Executive Officer

CME Group Berhad Announces the Re-designation of Tengku Indera Pahlawan Tengku Putra Alhaj Bin Tengku Azman Shah Alhaj from Independent and Non Executive Member of Nomination Committee to Chairman of Nomination Committee

CME Group Berhad Announces the Demise of Dato' Khairi Bin Mohamad, Independent and Non Executive Chairman of Remuneration Committee

CME Group Berhad Updates on Its Lawsuits

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies